OncoCyte Corp (NASDAQ:OCX)
| 3.40 BATS BZX Real-Time Price As of 1:46pm ET |  -0.125 / -3.55%Today’s Change | 1.41 Today|||52-Week Range 6.57 | +42.05% Year-to-Date |
Latest OCX News | Press Releases
No recent news for OncoCyte Corp.
Today’s Trading
| Previous close | 3.52 |
| Today’s open | 3.41 |
| Day’s range | 3.35 - 3.42 |
| Volume | 13,919 |
| Average volume (3 months) | 585,428 |
| Market cap | $313.2M |
Data as of 1:46pm ET, 10/22/2021
Growth & Valuation
| Earnings growth (last year) | -4.55% |
| Earnings growth (this year) | +17.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 128.69 |
| Price/Book | 7.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SPPISpectrum Pharmaceuti... | -0.01 | -0.51% |
| PDSBPDS Biotechnology Co... | -0.03 | -0.26% |
| WWHCW World Corp | -1.73 | -35.74% |
| CTMXCytomX Therapeutics ... | +0.12 | +2.35% |
Data as of 1:53pm ET, 10/22/2021
Financials
| Next reporting date | November 18, 2021 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$29.9M |
| Net profit margin | -2,461.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
